arteriosclerosis obliterans

Search with Google Search with Bing
Information
Disease name
arteriosclerosis obliterans
Disease ID
DOID:5160
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT05083299 Completed Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate January 28, 2020 January 20, 2022
NCT00712946 Completed Preoperative Heart Rate Variability and Baroreflex Sensitivity in ASO Patients During Various Sleep Stages March 2006 December 2010
NCT00823849 Completed Phase 4 Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker October 2008 March 2010
NCT01518205 Completed N/A HELP-Apheresis in Diabetic Ischemic Foot Treatment (H.A.D.I.F) February 2012 December 2015
NCT00145262 Unknown status TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation August 2003
NCT02431234 Unknown status Arterial Calcification in the Diabetes February 2014 September 2018
NCT02864654 Unknown status Phase 1/Phase 2 Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia July 2016 July 2018
NCT02877173 Unknown status Phase 2 A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans August 2016 December 2017
NCT00912756 Unknown status Phase 4 Sufficient Treatment of Peripheral Intervention by Cilostazol March 2009 September 2012
Disase is a (Disease Ontology)
DOID:2349
Cross Reference ID (Disease Ontology)
MESH:D001162
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:60625000
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0003851
MeSH unique ID (MeSH (Medical Subject Headings))
D001162